Target Name: MIR30A
NCBI ID: G407029
Review Report on MIR30A Target / Biomarker Content of Review Report on MIR30A Target / Biomarker
MIR30A
Other Name(s): microRNA 30a | MIRN30A | hsa-miR-30a-3p | mir-30a | hsa-miR-30a-5p | MicroRNA 30a | hsa-mir-30a

MicroRNA 30a: A Non-Coding RNA Molecule with A Range of Functions in The Cell

MicroRNA (miRNA) 30a is a non-coding RNA molecule that plays a crucial role in various biological processes. It is a key regulator of gene expression and has been implicated in a wide range of cellular processes, including cell growth, differentiation, and apoptosis . MIR30A is a specific miRNA that has been of particular interest due to its involvement in several diseases, including cancer.

MIR30A is a member of the miRNA family, which are small non-coding RNAs that are typically transcribed from DNA and can be translated into proteins or RNA. The miRNA family plays a central role in post-transcriptional gene regulation, as well as cell signaling and survival.

MIR30A has been shown to have a number of different functions in the cell. One of its well-established functions is its role as a negative regulator of the cell cycle. MIR30A has been shown to interact with the protein kinase p21, which is a key regulator of the cell cycle. When p21 is activated, it inhibits the activity of MIR30A, preventing it from binding to its target genes and thereby regulating the cell cycle.

Another function of MIR30A is its role as a regulator of cell apoptosis. apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. MIR30A has been shown to play a role in regulating apoptosis by suppressing the production of pro-apoptotic molecules, such as Bax.

MIR30A has also been shown to be involved in the regulation of cell migration. Cell migration is a critical process that is involved in the development of tissues and organs, as well as the response to external stimuli. MIR30A has been shown to play a role in Regulating cell migration by suppressing the production of molecules that promote cell adhesion and migration.

MIR30A has also been shown to be involved in the regulation of gene expression. miRNA genes are known for their ability to target specific mRNAs for translation into protein. MIR30A has also been shown to interact with the protein SIRT1, which is a known regulator of gene expression. . When SIRT1 is activated, it can interact with MIR30A, preventing it from binding to its target mRNAs and thereby regulating gene expression.

MIR30A has been implicated in a wide range of diseases, including cancer. For example, studies have shown that MIR30A is often expressed in various types of cancer, and that its levels are often elevated in these tumors. This suggests that MIR30A may be a potential drug target or biomarker for cancer.

In addition to its potential clinical applications, MIR30A is also of interest to researchers because of its genetic stability. MIR30A is a highly conserved gene that is expressed in a wide range of organisms, including humans. This makes it an attractive target for researchers who are interested in understanding the fundamental mechanisms of miRNA regulation.

In conclusion, MIR30A is a microRNA that has a wide range of functions in the cell. Its role as a negative regulator of the cell cycle, its involvement in cell apoptosis, its role in cell migration, and its involvement in gene expression make it an attractive target for researchers who are interested in understanding the fundamental mechanisms of miRNA regulation. Its genetic stability also makes it an attractive candidate for further study. Further research is needed to fully understand the role of MIR30A in the cell and its potential as a drug target or biomarker.

Protein Name: MicroRNA 30a

The "MIR30A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR30A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186